Response to "Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease".
暂无分享，去创建一个
[1] Kathryn J Fowler,et al. Derivation and Internal Validation of a Clinical Prediction Tool to Predict Nonalcoholic Fatty Liver Disease in Patients With Crohn's Disease. , 2020, Inflammatory bowel diseases.
[2] S. Gitto,et al. Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease , 2018, Cell Death & Disease.
[3] A. Bitton,et al. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease , 2016, Inflammatory bowel diseases.
[4] G. Garg,et al. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.
[5] S. Upala,et al. Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis. , 2017, Annals of hepatology.